Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genesis Biotechnology Group
Hamilton Township / Trenton area, New Jersey, United Statesgenesisbiotechgroup.com ↗
- Ownership
- Private
- Employees
- ~153
- Development stage
- Other
01
Overview
Genesis Biotechnology Group operates as a vertically integrated consortium with capabilities spanning basic science research through clinical diagnostics and contract preclinical-to-clinical services. It has not publicly disclosed late-stage or commercialized proprietary therapeutics but provides comprehensive support to external partners from target identification through IND filing and early-phase trials.
- Therapeutic areas
- OncologyDermatologyOphthalmologyOther
- Modalities
- Small moleculeProtein (including recombinant protein)Cell therapyDiagnostic assayPeptidesMonoclonal antibody
- Industry
- Contract Research Organization
02
Partnerships
Notable acquisition of BioBlocks to expand medicinal chemistry capabilities. No major disclosed pharma partnerships.
Beyond the preview
Go deeper on Genesis Biotechnology Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genesis Biotechnology Group.